A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) (NCT06739122)

🧪 Interventions in This Study

• Dulaglutide (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (51 Sites)

Showing the first 25 of 51 sites.

• University of Arizona — Tucson, Arizona
• Arkansas Childrens Hospital — Little Rock, Arkansas
• Division of Endocrinology, Diabetes, and Metabolism — Los Angeles, California
• UCLA Mattel Children's Hospital — Los Angeles, California
• University of California, San Francisco — San Francisco, California
• Children's Hospital of Colorado — Denver, Colorado
• Yale Diabetes Research — New Haven, Connecticut
• Emerson Clinical Research Institute — Washington D.C., District of Columbia
• Children's National Medical Center — Washington D.C., District of Columbia
• Nemours Children's Health — Jacksonville, Florida
• D&H National Research Centers, Inc — Miami, Florida
• AdventHealth Orlando — Orlando, Florida
• D&H Tamarac Research Center, LLC — Tamarac, Florida
• University of South Florida — Tampa, Florida
• Children's Healthcare of Atlanta - Center for Advanced Pediatrics — Atlanta, Georgia
• Centricity Research Columbus Endocrinology — Columbus, Georgia
• St. Luke's Children's Endocrinology and Diabetes — Boise, Idaho
• University of Illinois at Chicago — Chicago, Illinois
• Center for Diabetes and Metabolic Diseases Indiana University — Indianapolis, Indiana
• University of Iowa Stead Family Children's Hospitals — Iowa City, Iowa
• Norton Children's Endocrinology — Louisville, Kentucky
• Johns Hopkins University School of Medicine — Baltimore, Maryland
• University of Mississippi Medical Center — Jackson, Mississippi
• University of New Mexico Hospital — Albuquerque, New Mexico
• WBMD Pediatrics — Buffalo, New York

📞 Contact the Study Coordinator

Phone: (317) 615-4559

Email: LillyTrials@Lilly.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Type 2 Diabetes

• Continuous Glucose Monitoring System Feasibility in Youth With T2D — San Francisco, California
• Diabetes Nutrition Education and Healthy Food Resource for AIANs With T2D — Oklahoma City, Oklahoma
• Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus — Minneapolis, Minnesota
• Diabetes Medical Nutrition Therapy in Southeastern African American Women — Nashville, Tennessee
• E3 Diabetes - Closing the Gap in Diabetes Control — Chicago, Illinois
• Recreational Basketball to Increase Participation in Diabetes Prevention — Atlanta, Georgia

Explore by condition: All Type 2 Diabetes clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.